Nutraceutical (NUTR-NASDAQ) Shares Added to Approved List

July 26, 2010 - PRLog -- Nutraceutical International (NUTR) was added to the Approved Buy List with a Top Qualifier rating. Entry is initially recommended above 15.50 but below 16.00. The forgoing price parameters are subject to revision regularly. Purchase should be withheld below 15.50 according to the Protogenia risk management algorithm and protocol. The Fair Market Value is 18..35 and the Relative Strength Combination rank places the shares in the 20% of all listed stocks. Nutraceutical is expected to release quarterly financial results during week ending July 30.

For further information contact Protogenia Investments, LLC. through Chief Investment Officer, Larry Kase at larrykase@comcast.net. Protogenia conducts and publishes investment research independent from any broker/ dealer affiliation. Protogenia plans to fund and launch a new hedge fund during the Third Quarter 2010.

# # #

Protogenia Investments, LLC is an investment securities research and management company. Investment prospects are assessed through a series of proprietary filters. Buy, sell and other determinations are based upon a proprietary quantitative algorithm.